SN25006 - Midas Database for Drug Pricing and Utilization, including Disease and Patient functionality (Канада - Тендер #71764747)

Basic Information

Reference Number

cb-271-31341040

Issuing Organization

Patented Medicine Prices Review Board (PMPRB)

Solicitation Type

ACAN - Advance Contract Award Notice (Formal)

Solicitation Number

SN25006

Title

Midas Database for Drug Pricing and Utilization, including Disease and Patient functionality

Source ID

PWGSC

Agreement Types

Canada-Chile Free Trade Agreement (CCFTA)

Canada-Colombia Free Trade Agreement

Canada-European Union Comprehensive Economic and Trade Agreement(CETA)

Canada-Honduras Free Trade Agreement

Canada-Korea Free Trade Agreement

Canada-Panama Free Trade Agreement

Canada-Peru Free Trade Agreement (CPFTA)

Canadian Free Trade Agreement (CFTA)

Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP)

North American Free Trade Agreement (NAFTA)

World Trade Organization Agreement on Government Procurement (WTO-AGP)

Canada-UK Trade Continuity Agreement (Canada-UK TCA)

Canada-Ukraine Free Trade Agreement (CUFTA)

Details

Location

Canada

Dates

Publication

2026/04/08 12:00:00 AM EDT

Closing Date

2026/04/23 03:00:00 PM EDT

Contact Information

Sylvie Beaudoin

(343) 575-0363

sylvie.beaudoin@pmprb-Cepmb.gc.ca

Description

The Patented Medicine Prices Review Board (PMPRB) is a quasi-judicial body responsible for protecting Canadians from patent abuse related to patented medicine prices. To do so, the PMPRB reviews the prices of these medicines and intervenes as necessary in the form of a hearing, during which a panel might determine that the prices are excessive.

The PMPRB also contributes to a greater understanding of the biopharmaceutical ecosystem by publishing annual reports on trends in sales, pricing, and research and development spending. Additionally, the PMPRB provides neutral, relevant, and timely ad hoc analysis on pharmaceutical trends, at the Minister’s request.

The PMPRB has a requirement for the supply of an existing, fully developed database containing drug utilization data [S(2.1][JB2.2]for the retail and hospital sector respecting relevant market variables such as price (at ex-factory, wholesale and retail level in local and US currency), quantities and revenue of medicines sold in Canada and all OECD countries. The information provided must have been collected [S(3.1][JB3.2]in a complete, objective and non-biased fashion by surveying hospitals, pharmacies and wholesalers across Canada and all OECD countries.

International price and market trends continue to be areas of research for both PMPRB policy work and as part of research priorities identified by the NPDUIS AC.

See more Disclaimer Government of Canada (GC) tender notices and awards, solicitation documents and tender attachments are available free of charge and without registration on canadabuys.canada.ca/en/tender-opportunities, the authoritative location for GC tenders.

You may have received this tender notice or award through a third-party distributor. The Government of Canada is not responsible for any tender notices and/or related documents and attachments not accessed directly through canadabuys.canada.ca/en/tender-opportunities.

This Government of Canada tender notice or tender award carries an Open Government Licence - Canada that governs its use. Related solicitation documents and/or tender attachments are copyright protected. Please refer to the section about Commercial Reproduction in the canadabuys.canada.ca/en Terms and Conditions for more information.

Contains information licensed under the Open Government license - Canada. Contains data reproduced and distributed with the permission of the Government of Canada, on an "as is" basis.

Источник закупки

Перейти

Импорт - Экспорт по стране Канада